Plain-English translation of NCT03250078 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Neoplasms research guide →This trial is looking for early signs of pancreatic cancer in people who are at higher risk because of their family history or because they carry certain genes linked to the disease. Researchers will use MRI scans and blood tests to monitor participants over three years, hoping to catch any problems early when treatment options may be better.
Pancreatic cancer is very hard to detect early, and people with a family history or genetic mutations have a much higher chance of developing it. This study aims to see if regular screening can find cancerous changes before symptoms appear, which could save lives.
You likely qualify if…
You likely don't qualify if…
You will visit the study site every 6 months for three years to give a blood sample and complete a short 5-minute survey about your emotional well-being. Once a year during this time, you'll also have an MRI scan of your pancreas (four scans total), and the study will cover all costs for these scans. If any abnormalities are found, a team of specialists will review the results and discuss them with you.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States
Sponsor
Nuvance Health
Enrollment target
~200 participants
Started
November 2016
Primary completion
November 2030
Age range
50 Years – 90 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tammy Lo, APRN
Nuvance Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.